CoreFirst Bank & Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
CoreFirst Bank & Trust's AMGN Position: Q2 2026 in Review
CoreFirst Bank & Trust increased its Amgen (AMGN) stake by 0.38% in Q2 2026, buying an estimated $3.42K and bringing the position to 2,643 shares worth $957K. The position accounts for 0.48% of the portfolio, ranked #48.
CoreFirst Bank & Trust first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.62M in Q1 2021. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- CoreFirst Bank & Trust held 2,643 shares of Amgen worth $957K as of Q2 2026.
- CoreFirst Bank & Trust bought 10 Amgen shares in Q2 2026, an estimated $3.42K.
- Amgen made up 0.48% of CoreFirst Bank & Trust's portfolio in Q2 2026, its #48 holding.
- CoreFirst Bank & Trust first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- CoreFirst Bank & Trust's Amgen position peaked at $1.62M in Q1 2021.
- 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on CoreFirst Bank & Trust's 13F filing for Q2 2026, filed 5 Aug 2026.